Chart calendar Arrowhead Pharmaceuticals, Inc.

3.wF5HBPdaGooMEp3c3aqHfi4UA9WCI5x3T513Q1zkf50.hisDTY8iW9xaXtuwq-TiP2hwSbjwTfoTdtomImi-Cfn2HClsujNVvnZorQ~c682567b0c0bfc27cf5c0868657f713b

Upcoming events on Arrowhead Pharmaceuticals, Inc.

No events available

Past events on Arrowhead Pharmaceuticals, Inc.

07/05/2026

Earnings presentation

21:30
19/03/2026

Présentation aux Actionnaires / Analystes

17:00
19/03/2026

Annual General Meeting

17:00
05/02/2026

Earnings release - Q1 2026

05/02/2026

Earnings presentation

21:30
06/01/2026

Information meeting

16:30
25/11/2025

Earnings presentation

21:30
18/11/2025

Information meeting

18:30
07/08/2025

Earnings presentation

21:30

Annual results

Fiscal PeriodSeptember 2023 2024 2025 2026 2027 2028
Net sales
Million USD
Released
Forecast
Spread
241
264
-8.67%
3,55
61,6
-94.24%
829
757
9.51%

444


337


573

EBITDA
Million USD
Released
Forecast
Spread
-193
-159
-21.17%
-582
-536
-8.69%
122
126
-3.14%

-346


-449


-306

EBIT
Million USD
Released
Forecast
Spread
-205
-162
-26.6%
-601
-557
-7.95%
98,3
73,1
34.59%

-428


-581


-424

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-206
-159
-29.54%
-612
-552
-10.94%
51,5
4,70
996.14%

-459


-603


-400

Net income
Million USD
Released
Forecast
Spread
-205
-151
-36.13%
-599
-535
-11.97%
-1,63
1,67
-197.46%

-449


-592


-412

EPS
USD
Released
Forecast
Spread
-1,92
-1,51
-26.73%
-5,00
-4,52
-10.67%
-0,01
-0,01
-33.33%

-3,16


-4,09


-2,82

Announcement Date29/11/2326/11/2425/11/25-

Quarterly results

Fiscal PeriodMarch 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
58,9
-
2,50
19,1
-86.88%
543
116
366.77%
27,8
29,0
-4.28%
256
157
63.04%
264
231
14.38%
73,7
71,7
2.83%

46,7


78,8


42,6


31,2


33,2


159

EBITDA
Million USD
Released
Forecast
Spread
-157
-134
-17.65%






-159
-90,0
-77.04%
50,5
32,0
57.88%
47,2
223
-78.8%

-149


-133


-93,4













EBIT
Million USD
Released
Forecast
Spread
-162
-121
-34.53%
-161
-148
-8.76%
381
-50,2
859.27%
-166
-136
-21.62%
44,1
-25,3
274.12%
40,8
2,63
1451.82%
-141
-154
8.4%

-177


-155


-204


-211


-216


-162

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-173
-102
-69.53%
-175
-145
-20.88%
370
16,5
2137.84%
-179
-135
-33.1%
36,1
-41,9
186.23%
28,3
-34,0
183.15%
-138
-153
10.35%

-178


-179


-216


-222


-229


-173

Net income
Million USD
Released
Forecast
Spread
-171
-97,0
-75.83%
-173
-139
-24.41%
370
-12,5
3072.48%
-175
-137
-28.17%
-23,8
-41,4
42.66%
30,8
-27,6
211.63%
-133
-161
17.33%

-180


-165


-216


-223


-230


-174

EPS
USD
Released
Forecast
Spread
-1,37
-0,87
-57.26%
-1,39
-0,38
-264.59%
2,75
0,01
34189.28%
-1,26
-0,99
-27.39%
-0,18
-0,30
39.08%
0,22
-0,15
251.14%
-0,93
-1,12
16.59%

-1,25


-1,16


-1,35


-1,46


-1,49


-0,75

Announcement Date26/11/2410/02/2512/05/2507/08/2525/11/2505/02/2607/05/26------
Today

Présentation aux Actionnaires / Analystes

14:00
Today

Présentation aux Actionnaires / Analystes

16:00
Today

Annual General Meeting

16:00
22/05/2026

Earnings presentation

08:00
22/05/2026

Annual General Meeting

03:00
26/05/2026

Annual General Meeting

Day
26/05/2026

Présentation aux Actionnaires / Analystes

17:00
26/05/2026

Extraordinary General Meeting

12:00
26/05/2026

Annual General Meeting

03:00
26/05/2026

Sales and Revenue Release - Q1 2026

Day

Past sector events for Arrowhead Pharmaceuticals, Inc.

Today

Annual General Meeting

Day
Today

Earnings presentation

03:00
Today

Annual General Meeting

03:00
20/05/2026

Earnings release - Q1 2026

20/05/2026

Earnings presentation

21:30
20/05/2026

Annual General Meeting

03:00
20/05/2026

Présentation aux Actionnaires / Analystes

03:00
20/05/2026

Annual General Meeting

03:00
20/05/2026

Annual General Meeting

14:00
20/05/2026

Présentation aux Actionnaires / Analystes

14:00

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ARWR Stock
  4. Calendar Arrowhead Pharmaceuticals, Inc.